Acute Myocardial InfarctionYAMINCT04427046
Acute Myocardial Infarction in Native Versus Non-native Young Population in Saudi Arabia
An observational study of Acute Myocardial Infarction, run by Saud Al Babtain Cardiac Center at 1 site in Saudi Arabia.
Trial summary
A retrospective study collecting the data of young patients admitted with diagnosis of Acute Myocardial Infarction. Read more about this study
- Who is it for?
- Ages 18 to 54 years
- Conditions the study is for
- Acute Myocardial Infarction
- How many people
- 600 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 9 Jun 2020to 30 Sep 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 54 years
- All sexes
- No healthy volunteers
- Adult
Study population: Young adults, saudi or non-saudi, with Acute Myocardial Infarction.
Who may be able to join
- <45 years old for male and <55 years old for female
- patients admitted with diagnosis of Acute Myocardial Infarction
Who cannot join
- <17 and >55 years old male and female
- patients admitted with diagnosis other than Acute Myocardial Infarction.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Clinical Presentation and Outcome of Acute Myocardial Infarction in Native Versus Non-native Young Population in Saudi Arabia
A retrospective study collecting the data of young patients admitted with diagnosis of Acute Myocardial Infarction.
Read the detailed description
A retrospective study investigating young adults aged <45 years for males and <55 years for females admitted at Saud Al Babtain Cardiac Center with diagnosis of Acute Myocardial Infarction, determining its risk factors for Coronary Artery Disease (CAD) related to cultural characteristics and common positive consanguinity of parents as well as the prevalent diabetes and smoking.
- Conditions
- Acute Myocardial Infarction
- Keywords
- Young, Saudi
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of young adults hospitalized with primary diagnosis of Acute Myocadial Infarction.
Clinical Presentation and Outcome of Acute Myocardial Infarction in Native Versus Non-native Young Population in Saudi Arabia
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jun 2020
- Study start9 Jun 2020
- Primary completion30 Jun 2022
- Study completion30 Sep 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Myocardial InfarctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 600 participants (actual)
Sponsor and investigators
- Lead sponsor
- Saud Al Babtain Cardiac Center
- Sponsor type
- Other government
- Responsible party
- Sponsor
- Investigators
- Ali Youssef, MD, Principal investigator, Saud Al Babtain Cardiac Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04427046
- Sponsor's protocol ID
- SBCC-2018-14
- Acronym
- YAMI
- Status last verified
- Oct 2022
- First submitted
- 9 Jun 2020
- Last updated
- 26 Oct 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Presentation and Outcome of Acute Myocardial Infarction in Native Versus Non-native Young Population in Saudi Arabia
- ClinicalTrials.gov ID
- NCT04427046
- Acronym / sponsor ID
- YAMI / SBCC-2018-14
- Conditions
- Acute Myocardial Infarction
- Keywords
- Young, Saudi
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 600 participants (actual)
- Lead sponsor
- Saud Al Babtain Cardiac CenterOther government
- Study start
- 9 Jun 2020 (actual)
- Primary completion
- 30 Jun 2022 (actual)
- Study completion
- 30 Sep 2022 (actual)
- First posted
- 11 Jun 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A retrospective study collecting the data of young patients admitted with diagnosis of Acute Myocardial Infarction.
Detailed description
A retrospective study investigating young adults aged <45 years for males and <55 years for females admitted at Saud Al Babtain Cardiac Center with diagnosis of Acute Myocardial Infarction, determining its risk factors for Coronary Artery Disease (CAD) related to cultural characteristics and common positive consanguinity of parents as well as the prevalent diabetes and smoking.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 to 54 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- Young adults, saudi or non-saudi, with Acute Myocardial Infarction.
Key inclusion criteria (2 listed)
- <45 years old for male and <55 years old for female
- patients admitted with diagnosis of Acute Myocardial Infarction
Key exclusion criteria (2 listed)
- <17 and >55 years old male and female
- patients admitted with diagnosis other than Acute Myocardial Infarction.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of young adults hospitalized with primary diagnosis of Acute Myocadial Infarction.
Time frame: 2 years
Clinical Presentation and Outcome of Acute Myocardial Infarction in Native Versus Non-native Young Population in Saudi Arabia
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Acute Myocardial Infarction
Recruiting
CRP Apheresis in Infarct-Related Cardiogenic Shock
Cardiogenic Shock, Acute Myocardial Infarction (AMI)
Enrolling by invitationPhase 3
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
Acute Myocardial Infarction
RecruitingObservational study
Cardiogenic Shock Working Group Registry
Cardiogenic Shock
RecruitingObservational study
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
RecruitingObservational study
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Heart Failure, Muscle Atrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ali Youssef, MD principal investigator
Saud Al Babtain Cardiac Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Myocardial Infarction, run by Saud Al Babtain Cardiac Center at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of young adults hospitalized with primary diagnosis of Acute Myocadial Infarction. (time frame: 2 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2022; AzTrials last refreshed its copy on 2 Nov 2026.